# FDA Inspection 1130379 - Biogen, Inc. - September 01, 2020

Source: https://www.keypedia.com/records/fda_inspections/biogen-inc/2f1b5a81-d499-4309-8375-2da077f63bb2
Source feed: FDA_Inspections

> FDA Inspection 1130379 for Biogen, Inc. on September 01, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1130379
- Company Name: Biogen, Inc.
- Inspection Date: 2020-09-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1190494 - 2022-11-04](https://www.keypedia.com/records/fda_inspections/biogen-inc/a8e3cb54-bb6a-4cff-8bba-632415562b8c)
- [FDA Inspection 1180550 - 2022-09-02](https://www.keypedia.com/records/fda_inspections/biogen-inc/82230e2a-bb3f-478e-ac66-d4ad9de96473)
- [FDA Inspection 1133055 - 2020-11-10](https://www.keypedia.com/records/fda_inspections/biogen-inc/22d822ad-d609-463f-8c8b-03990b9b04da)
- [FDA Inspection 1046583 - 2018-02-13](https://www.keypedia.com/records/fda_inspections/biogen-inc/e4528441-a6d3-46a9-bf79-0ede74540efd)
- [FDA Inspection 1008333 - 2017-04-06](https://www.keypedia.com/records/fda_inspections/biogen-inc/b10dee32-12db-4414-acb5-6ae0e258197d)

Company: https://www.keypedia.com/companies/biogen-inc/2cf09880-2ef1-4fb7-9690-fa729e4da5c4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c